Intravenous Benlysta is the first biologic treatment to be approved for children with lupus in Europ

Intravenous Benlysta is the first biologic treatment to be approved for children with lupus in Europe

European Commission has made a decision to extend to children five years and older, the existing adult indication for intravenous Benlysta

RSS Hunter • Oct 29, 2019